Comprehensive Data from 2,530 Oncology Projects Covering Medical, Hematology, and Radiation Oncology Worldwide
Konovo’s Oncology Therapeutic Breakdown delivers an in-depth look at global cancer care markets, leveraging insights from over 146,000 completes across 2,530 projects in the past three years. Our expansive panel of 2 million+ verified healthcare professionals spans medical oncologists, hematology-oncologists, hematologists, and radiation oncologists across the Americas, Europe, and Asia. With detailed incidence rates for key cancer types—from breast, lung, and prostate cancers to rare malignancies like sarcomas and CML—Konovo provides precise, representative data to inform pharmaceutical, biotech, and medical device strategies. Backed by rigorous quality controls and proprietary data collection technologies, our oncology market research empowers stakeholders to make faster, data-driven decisions in a highly competitive therapeutic area.
